杭州奥泰生物技术股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告

Core Viewpoint - The company, Hangzhou Aotai Biological Technology Co., Ltd., has announced the details regarding the share repurchase plan and the shareholding status of its top ten shareholders and top ten unrestricted shareholders as of January 21, 2026 [1][2]. Group 1 - The company's board of directors approved the share repurchase plan during the 19th meeting of the third board on January 21, 2026 [1]. - The details of the share repurchase plan were disclosed on January 22, 2026, on the Shanghai Stock Exchange website [1]. - The announcement includes the names, shareholding quantities, and shareholding ratios of the top ten shareholders and top ten unrestricted shareholders as of the day before the board meeting [1]. Group 2 - All shares of the company are unrestricted circulating shares, meaning the shareholding situation for the top ten shareholders and the top ten unrestricted shareholders is identical [2]. - The company ensures that the announcement contains no false records, misleading statements, or significant omissions, and the board takes legal responsibility for the content's authenticity, accuracy, and completeness [1].